DAA program to be expanded in community pharmacies
The Dose Administration Aids (DAA) program will be available to 70,000 more patients each year through community pharmacies, with the Federal Government announcing increased...
Management of apathy in patients with Alzheimer’s disease
People diagnosed with Alzheimer’s disease often experience symptoms of apathy, which can be treated by pharmacological and behavioural interventions.
The purpose of this evidence...
Medication adherence through community pharmacy intervention
Community pharmacist-led interventions have been shown to improve adherence and health outcomes for patients with chronic diseases but a number of barriers remain.
Researchers from...
Calculating the risk of glaucoma
More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...
My Health Record – where to from here?
While the My Health Record (MHR) opt-out date of January 31 has come and gone, people still have the option to permanently delete their...
E-cigarettes warning after link with pulmonary illness in US
A new statement on e-cigarettes has been issued by the Australian Government Department of Health.
The Australian Government Department of Health has issued a new...














